期刊文献+

丙氨酰谷氨酰胺联合乌司他丁治疗重症急性胰腺炎效果观察 被引量:6

Observation on the effect of alanylglutamine combined with ulinastatin in the treatment of severe acute pancreatitis
在线阅读 下载PDF
导出
摘要 目的观察丙氨酰谷氨酰胺联合乌司他丁治疗重症急性胰腺炎的临床效果。方法选取2018年1月-2019年9月郴州市第一人民医院南院收治的重症急性胰腺炎患者120例,采用随机数表法分为观察组和对照组各60例。对照组采用常规治疗,观察组在常规治疗的基础上采用丙氨酰谷氨酰胺联合乌司他丁治疗。比较2组患者的治疗效果、治疗前后炎性因子水平及肝肾功能改善情况。结果观察组的治疗总有效率为93.33%,高于对照组的70.00%(χ~2=10.909,P<0.01)。治疗后2组肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、C反应蛋白(CRP)、天门冬氨酸氨基转肽酶(AST)、丙氨酸氨基转肽酶(ALT)、总胆红素(TBil)及血清肌酐(SCr)水平均低于治疗前(P<0.05),且观察组低于对照组(P<0.05)。结论丙氨酰谷氨酰胺联合乌司他丁治疗重症急性胰腺炎的临床效果较好,可降低患者的炎性因子水平,改善患者的肝肾功能,缩短患者的症状缓解时间,促进患者病情的快速康复。 Objective To observe the clinical effect of alanyl glutamine combined with ulinastatin in the treatment of severe acute pancreatitis.Methods 120 cases of severe acute pancreatitis treated in the South Hospital of Chenzhou First People’s Hospital from January 2018 to September 2019 were selected.Random number table method was used to divide the observation group and control group,each of 60 cases.The control group was treated with conventional treatment,and the observation group was treated with alanylglutamine combined with ulinastatin on the basis of conventional treatment.The treatment effects,before and after treatment inflammatory factor levels,liver and kidney function improvement were compared.Results The total effective rate of treatment in the observation group was 93.33%,which was higher than 70.00%in the control group(χ~2=10.909,P<0.01).After treatment,tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),C-reactive protein(CRP),aspartate aminotransferase(AST),alanine aminotransferase(ALT),total bilirubin(TBil)and serum creatinine(SCr)levels were lower than before treatment(P<0.05),and the observation group were lower than the control group(P<0.05).Conclusion Alanylglutamine in combination with ulinastatin has a good clinical effect in treating severe acute pancreatitis,which can reduce the level of inflammatory factors in patients,improve the liver and kidney function of patients,shorten the time to relieve symptoms of patients,and promote rapid disease Rehabilitation.
作者 黄文超 HUAGN Wenchao(South Hospital of Chenzhou First People's Hospital^Hunan Province,Chenzhou 423000,China)
出处 《临床合理用药杂志》 2020年第11期8-9,22,共3页 Chinese Journal of Clinical Rational Drug Use
关键词 丙氨酰谷氨酰胺 乌司他丁 重症急性胰腺炎 炎性因子 肝肾功能 Alanylglutamine Ulinastatin Severe acute pancreatitis Inflammatory factors Liver and kidney function
  • 相关文献

参考文献10

二级参考文献86

  • 1Ellen Andersson,Jakob Axelsson,Gunilla Eckerwall,Daniel Ansari,Roland Andersson.Tissue factor in predicted severe acute pancreatitis[J].World Journal of Gastroenterology,2010,16(48):6128-6134. 被引量:26
  • 2庄岩,杨尹默,王维民,万远廉,黄延庭.急性胰腺炎鼠白细胞介素(IL)1β、IL-18、肿瘤坏死因子α、IL-1β转化酶的表达[J].中华实验外科杂志,2005,22(1):71-72. 被引量:34
  • 3严志汉,闵鹏秋,章士正.急性胰腺炎严重程度和预后评价的研究进展[J].中华放射学杂志,2005,39(4):432-435. 被引量:32
  • 4韩德五.肠源性内毒素血症在胰腺炎发病中的作用[J].世界华人消化杂志,2006,14(29):2825-2829. 被引量:19
  • 5Shi C, Zhao X, Lagergren A, Sigvardsson M, Wang X, Andersson R. Immune status and inflammatory re- sponse differ locally and systemically in severe acutepancreatitis. Scand J Gastroentero12006; 41:472-480.
  • 6Sekimoto M, Takada T, Kawarada Y, Hirata K, Ma- yumi T, Yoshida M, Hirota M, Kimura Y, Takeda K, Isaji S, Koizumi M, Otsuki M, Matsuno S. JPN Guidelines for the management of acute pancre- atitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobi- liary Pancreat Surg 2006; 13:10-24.
  • 7Curi R, Lagranha CJ, Doi SQ, Sellitti DF, Procopio J, Pithon-Curi TC, Corless M, Newsholme P. Molecu- lar mechanisms of glutamine action. J Cell Physiol 2005: 204:392-401.
  • 8MaUeo G, Mazzon E, Siriwardena AK, Cuzzocrea S. TNF-alpha as a therapeutic target in acute pancre- atitis--lessons from experimental models. Scientific- WorldJourna12007; 7:431-448.
  • 9Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9: 401-410.
  • 10Ren B, Wu H, Zhu J, Li D, Shen Y, Ying R, Dong G, Jing H. Ulinastatin attenuates lung ischemia-reper- fusion injury in rats by inhibiting tumor necrosis factor alpha. Transplant Proc 2006; 38:2777-2779.

共引文献115

同被引文献87

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部